GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹163 Cr | ₹170 Cr | ₹84 Cr | ₹88 Cr | ₹74 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹163 Cr |
| Mar2024 | ₹170 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹88 Cr |
| Mar2021 | ₹74 Cr |
How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹163 Cr | -4.09 | |
| Mar2024 | ₹170 Cr | 101.52 | |
| Mar2023 | ₹84 Cr | -4.05 | |
| Mar2022 | ₹88 Cr | 18.79 | |
| Mar2021 | ₹74 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹28,125.6 Cr | 2.3% | -8.6% | 3.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹414,713.0 Cr | -1.4% | -3.2% | -0.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹156,811.0 Cr | -1.9% | -8.7% | 1.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹139,052.0 Cr | -3.5% | -6.6% | 30.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,927.0 Cr | -4% | -8.3% | 6.3% | Stock Analytics | |
| CIPLA | ₹96,602.7 Cr | -1.9% | -11.9% | -19% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 2.3% |
-8.6% |
3.8% |
| SENSEX | 0.6% |
-11.1% |
-6.2% |
You may also like the below Video Courses